Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Blood (2023) 142 (Supplement 1): 174.

https://doi.org/10.1182/blood-2023-189835

Published: 2023

Journal Articles

Chromatin Accessibility Profiling to Increase Diagnostic Accuracy and Refine Cell-of-Origin Classification of Mature T-Cell Lymphomas

Blood (2021) 138 (Supplement 1): 809.

https://doi.org/10.1182/blood-2021-150034

Published: 2021

Journal Articles

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Michael Doubek, Mudr. Lukas Smolej, Martin Šimkovič, Anna Panovska, Renata Urbanova, Daniel Lysak, Evelyne Callet-Bauchu, Emmanuel Bachy, Lucile Baseggio, Emmanuelle Ferrant, Joris Diels, Jedelyn Cabrieto, Lasse Nielsen, Gilles Salles

Blood (2021) 138 (Supplement 1): 4679.

https://doi.org/10.1182/blood-2021-147927

Published: 2021

Journal Articles

Crystal-storing histiocytosis in Bing-Neel syndrome

Cécile Dumas, Lucile Baseggio

Blood (2021) 137 (7): 1000.

https://doi.org/10.1182/blood.2020009307

Published: 2021

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

One translocation for 2 lymphoid neoplasms

Guillaume Aussedat, Lucile Baseggio

Blood (2019) 133 (2): 180.

https://doi.org/10.1182/blood-2018-10-877357

Published: 2019

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Agathe Pruvot Debliquis, pharmD, Lucile Baseggio, MD, Marie-Christine Jacob, Sabrina Bouyer, Franck Genevieve, MD PhD, Julien Guy, MD, Caroline Mayeur-Rousse, MD, Nicolas Chapuis, PharmD, PhD, Hind Bennani, Thomas Matthes, MD, Bernard Drenou

Blood (2018) 132 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2018-99-115990

Published: 2018

Journal Articles

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Caroline Algrin, Elise Chapiro, Justine Saviellis, Anne Quinquenel, Anne-Sophie Michallet, MD PhD, David Ghez, MD PhD, Pierre Feugier, MD, Annie Brion, Cecile Tomowiak, MD, Luc-Matthieu Fornecker, Remy Gressin, MD, Laurent Sutton, MD, Karim Maloum, Catherine Settegrana, Lucile Baseggio, MD, Quentin Vincent, Florence Nguyen-Khac, MD PhD, Véronique Leblond

Blood (2017) 130 (Supplement 1): 4310.

https://doi.org/10.1182/blood.V130.Suppl_1.4310.4310

Published: 2017

Journal Articles

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Blood (2017) 130 (Supplement 1): 4062.

https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062

Published: 2017

Journal Articles

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Gilles Salles, MD PhD, Lukas Smolej, MD PhD, Emmanuel Bachy, Lucile Baseggio, MD, Hervé Besson, Ruben Hermans, Nollaig Healy, Jamie Garside, Wafae Iraqi, Joris Diels, Finlay MacDougall, Corinna Pick-Lauer, Martin Spacek, Renata Urbanova, Daniel Lysak, Evelyne Callet-Bauchu, Michael Doubek, MD PhD

Blood (2017) 130 (Supplement 1): 5342.

https://doi.org/10.1182/blood.V130.Suppl_1.5342.5342

Published: 2017

Journal Articles

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Bruno Tesson, Sarah Huet, Béatrice Grange, Laurent Jallades, Lucile Baseggio, Pascale Felman, Alexandra Traverse-Glehen, Jean-Pierre Magaud, Jean-Christophe Lega, Christine Bole-Feysot, Gilles Salles, Evelyne Callet-Bauchu, Pierre Sujobert

Blood (2017) 130 (10): 1267–1269.

https://doi.org/10.1182/blood-2017-03-776674

Published: 2017

Includes: Supplemental data

Journal Articles

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations

Blood (2017) 129 (8): 1042–1045.

https://doi.org/10.1182/blood-2016-11-751024

Published: 2017

Includes: Supplemental data

Journal Articles

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATE TM and RESONATE-2 TM with the French Lyon-Sud Database

Gilles A. Salles, Lucile Baseggio, PharmD, PhD, Emmanuel Bachy, MD PhD, Clementine Sarkozy, MD, Herve Ghesquieres, MD PhD, Joris Diels, PhD, Hervé Besson, PhD, Finlay MacDougall, BA, Ruben Hermans, PhD MSc, Nollaig Healy, PhD, Jamie Garside, MSc, Wafae Iraqi, PharmD, PhD, Evelyne Callet-Bauchu, MD PhD

Blood (2016) 128 (22): 2039.

https://doi.org/10.1182/blood.V128.22.2039.2039

Published: 2016

Journal Articles

Mutational Status of Splenic Diffuse Red Pulp Small B-Cell Lymphoma Revealed By Whole Exome Sequencing

Nerea Martinez, Carmen Almaraz, Manuela Mollejo, Yolanda Campos-Martin, Sophia Derdak, Laura Cereceda, Alexandra Traverse-Glehen, Aurelie Verney, Lucile Baseggio, Fanny Camacho, Jose Pedro Vaque, Sergi Beltran, Ivo Gut, Miguel Angel A. Piris

Blood (2015) 126 (23): 1448.

https://doi.org/10.1182/blood.V126.23.1448.1448

Published: 2015

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs

Blood (2014) 124 (21): 4485.

https://doi.org/10.1182/blood.V124.21.4485.4485

Published: 2014

Journal Articles

Prognostic Impact Of Somatic NOTCH2 Mutation In Splenic Marginal Zone Lymphoma

Caroline Algrin, Gabriel Brisou, Kheira Beldjord, MD, PhD, Nicolas Mounier, MD, PhD, Francoise Berger, Lucile Baseggio, Aurélie Verney, Gilles Andre Salles, MD, PhD, Bertrand Coiffier, MD, PhD, Josette Briere, MD, Alexandra Traverse-Glehen, Catherine Thieblemont, MD, PhD

Blood (2013) 122 (21): 4247.

https://doi.org/10.1182/blood.V122.21.4247.4247

Published: 2013

Journal Articles

Toll-Like Receptor Profiles In Splenic Marginal Zone B-Cell Lymphoma and Splenic Diffuse Red Pulp B-Cell Lymphoma

Aurélie Verney, Alexandra Traverse-Glehen, Evelyne Callet-Bauchu, MD, PhD, Francoise Berger, Laurent Jallades, jean-Pierre Magaud, Pascale Felman, Gilles Andre Salles, MD, PhD, Lucile Baseggio

Blood (2013) 122 (21): 3009.

https://doi.org/10.1182/blood.V122.21.3009.3009

Published: 2013

Journal Articles

Strong Cell Surface Expression of the Toll-Like Receptor Homolog CD180 Identifies Circulating Cells of Marginal Zone Lymphoma From Other B-Cell Malignancies

Laurent Miguet, Lucile Baseggio, Sarah Lennon, Pascale Felman, Luc Fornecker, Anne-Cecile Galoisy, Caroline Mayeur-Rousse, Raoul Herbrecht, Alice Eischen, Sarah Cianferani, Laurent Mauvieux

Blood (2012) 120 (21): 1542.

https://doi.org/10.1182/blood.V120.21.1542.1542

Published: 2012

NARROW

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Chromatin Accessibility Profiling to Increase Diagnostic Accuracy and Refine Cell-of-Origin Classification of Mature T-Cell Lymphomas

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Crystal-storing histiocytosis in Bing-Neel syndrome

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

One translocation for 2 lymphoid neoplasms

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATE TM and RESONATE-2 TM with the French Lyon-Sud Database

Mutational Status of Splenic Diffuse Red Pulp Small B-Cell Lymphoma Revealed By Whole Exome Sequencing

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs

Prognostic Impact Of Somatic NOTCH2 Mutation In Splenic Marginal Zone Lymphoma

Toll-Like Receptor Profiles In Splenic Marginal Zone B-Cell Lymphoma and Splenic Diffuse Red Pulp B-Cell Lymphoma

Strong Cell Surface Expression of the Toll-Like Receptor Homolog CD180 Identifies Circulating Cells of Marginal Zone Lymphoma From Other B-Cell Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only